Susan G. Kreissman
Advanced in Histiocytosis
Advanced in Histiocytosis

Overview

Susan Kreissman is a Pediatrics provider in Durham, North Carolina. Dr. Kreissman has been practicing medicine for over 40 years and is rated as an Advanced provider by MediFind in the treatment of Histiocytosis. Her top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hepatoblastoma, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 30 peer reviewed articles and participating in 48 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has participated in 10 clinical trials in the study of Histiocytosis.

Graduate Institution
New York University Mount Sinai School Of Medicine, 1985
Specialties
Pediatrics
Licenses
Pediatric Hematology-Oncology in NC
Board Certifications
American Board Of Pediatrics, Pediatric Hematology-Oncology
Fellowships
Pediatric Hematology-Oncology, Children's Hospital, Dana Farber Cancer Center (Massachusetts)
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Piedmont
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 4 Less Insurance Carriers -

Locations

Duke Children's Health Center Hematology/Oncology Clinic
2301 Erwin Rd, Durham, NC 27710
Other Locations
Duke Children's Hematology/Oncology Creekstone
4709 Creekstone Dr, Durham, NC 27703
Duke Children's Hospital & Health Center
2301 Erwin Rd, Durham, NC 27710

Additional Areas of Focus

Dr. Kreissman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


48 Clinical Trials

Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Computerized Cognitive Training for Pediatric Brain Tumor Patients: A Pilot Study
Renal Tumors Classification, Biology, and Banking Study
Key Adverse Events After Childhood Cancer
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
View 46 Less Clinical Trials
Similar Doctors
Vinod K. Prasad
Experienced in Histiocytosis
Experienced in Histiocytosis

Duke Children's Health Center Bone Marrow Transplant Clinic

2301 Erwin Rd, 
Durham, NC 
 (10.1 miles away)
Experience:
39+ years
Languages Spoken:
English, Hindi
Offers Telehealth

For more than 20 years, I have had the privilege of taking care of children with some of the most difficult diagnoses, including leukemia, lymphoma, and other cancers, CGD and other immune deficiencies, thalassemia, sickle cell disease, and other blood disorders, and leukodystrophy, MPS, and other inherited disorders. Specializing in bone marrow transplants and hematopoietic cell transplants, I strive for my patients’ success. I feel fortunate to be providing care during a time when advancements in the medical field, fueled by incredible discoveries in immunology, drug development, genomics, and computing, have brought us closer to providing a good donor for almost all patients requiring a BMT or HCT. Dr. Prasad is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Graft Versus Host Disease (GvHD), Autoimmune Hemolytic Anemia, Pure Red Cell Aplasia, Non-Langerhans-Cell Histiocytosis, and Bone Marrow Transplant.

Kris M. Mahadeo
Experienced in Histiocytosis
Pediatric Hematology Oncology | Pediatrics
Experienced in Histiocytosis
Pediatric Hematology Oncology | Pediatrics

Duke Children's Health Center Bone Marrow Transplant Clinic

2301 Erwin Rd, 
Durham, NC 
 (10.1 miles away)
Experience:
16+ years
Languages Spoken:
English

I care for patients and families seeking bone marrow transplants, cellular therapies, and gene therapies for high-risk cancers, genetic and metabolic disorders, and primary immune deficiencies. I work closely with a comprehensive team to ensure the best long-term outcomes and quality of life. I am attentive to the needs of my patients, as well as their caregivers and families. In my spare time, I enjoy traveling and exploring new cultures. Dr. Mahadeo is rated as an Advanced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Hepatic Venoocclusive Disease with Immunodeficiency, Leukemia, Infantile Neutropenia, Bone Marrow Transplant, and Tissue Biopsy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kreissman's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 11 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile